The effect of sertindole on sensory gating and cognition in healthy volunteers

Trial Profile

The effect of sertindole on sensory gating and cognition in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2012

At a glance

  • Drugs Sertindole (Primary)
  • Indications Psychotic disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Feb 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 05 Jun 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 05 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top